All subjects enrolled in Island Pharmaceutical’s phase 2b arm of phase 2a/b PROTECT trial of ISLA-101 in dengue fever Phase 2b study will explore ability of ISLA-101 to reduce symptoms of a person ...

All subjects enrolled in Island Pharmaceutical’s phase 2b arm of phase 2a/b PROTECT trial of ISLA-101 in dengue fever Phase 2b study will explore ability of ISLA-101 to reduce symptoms of a ...

All subjects have now been enrolled in Island Pharmaceutical’s phase 2b arm of its ISLA-101 trial in dengue fever. Don't miss out on the headlines from Stockhead. Followed categories will be ...

The phase 2a study examined the prophylactic (preventative) arm of ISLA-101 in dengue fever and involved four subjects with a 3:1 randomisation ration of (active treatment to placebo). Phase 2b ...

200 cases of dengue fever have been recorded for the Western Division since the beginning of this year and the Ministry of Health has declared an outbreak in the Western Division. The Health ...